Loading...
Loading...
BioMarin Pharmaceutical Inc.
BMRN shares spiked 7.7% to $104.30 after Sarepta reported the USPTO decision in patent interference case with BioMarin. Share volume totaled 1.7 million, compared to an all-day average of 1.3 million
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
